Back

Nonagenarian patients with ATTR cardiac amyloidosis: should they be treated with tafamidis?

European Heart Journal

7 August 2025
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR DISEASE IN SPECIFIC POPULATIONS

Contributors

Antoine Jobbé-Duval
Antoine Jobbé-Duval

Author

Medipole Lyon-Villeurbanne Villeurbanne , France

Thibaud Damy
Thibaud Damy

Author

University Hospital Henri Mondor Creteil , France

Amaury Broussier
Amaury Broussier

Author

You may be interested in
thumbnail
Congress Presentation
Q&A
31 August 2025
thumbnail
Congress Presentation
Effects of tafamidis on quantification of myocardial amyloid deposits in patients with transthyretin amyloid cardiomyopathy
30 June 2021
thumbnail
Congress Presentation
Evolving the understanding of TTR's role in health and disease​
31 August 2025
thumbnail
Congress Presentation
Prevalence and characterization of concealed cardiac amyloidosis among unselected elderly patients undergoing post-mortem examination
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources